Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intermittent Scanning Glucose Monitoring or Predicted Low Suspend Pump Treatment: Does It Impact Time in Glucose Target and Treatment Preference? The QUEST Randomized Crossover Study.
Schierloh U, Aguayo GA, Schritz A, Fichelle M, De Melo Dias C, Vaillant MT, Cohen O, Gies I, de Beaufort C. Schierloh U, et al. Among authors: cohen o. Front Endocrinol (Lausanne). 2022 May 31;13:870916. doi: 10.3389/fendo.2022.870916. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35712259 Free PMC article. Clinical Trial.
Improved glycemic control through continuous glucose sensor-augmented insulin pump therapy: prospective results from a community and academic practice patient registry.
Cohen O, Körner A, Chlup R, Zoupas CS, Ragozin AK, Wudi K, Bartaskova D, Pappas A, Niederland T, Taybani Z, Barák L, Vazeou A; Central and Eastern Europe, Greece, and Israel Continuous Glucose Sensing Collaborative Study Group. Cohen O, et al. J Diabetes Sci Technol. 2009 Jul 1;3(4):804-11. doi: 10.1177/193229680900300429. J Diabetes Sci Technol. 2009. PMID: 20144331 Free PMC article.
Effect of prandial treatment timing adjustment, based on continuous glucose monitoring, in patients with type 2 diabetes uncontrolled with once-daily basal insulin: A randomized, phase IV study.
Ilany J, Bhandari H, Nabriski D, Toledano Y, Konvalina N, Cohen O. Ilany J, et al. Among authors: cohen o. Diabetes Obes Metab. 2018 May;20(5):1186-1192. doi: 10.1111/dom.13214. Epub 2018 Mar 7. Diabetes Obes Metab. 2018. PMID: 29316176 Free PMC article. Clinical Trial.
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
Bosi E, Choudhary P, de Valk HW, Lablanche S, Castañeda J, de Portu S, Da Silva J, Ré R, Vorrink-de Groot L, Shin J, Kaufman FR, Cohen O; SMILE Study Group. Bosi E, et al. Among authors: cohen o. Lancet Diabetes Endocrinol. 2019 Jun;7(6):462-472. doi: 10.1016/S2213-8587(19)30150-0. Epub 2019 Apr 29. Lancet Diabetes Endocrinol. 2019. PMID: 31047902 Clinical Trial.
1,104 results